This page shows you your search results in order of date.
Order by Relevance | Date
Total 5053 results found since Jan 2013.
24-year-old woman • large joint arthralgias • history of type 1 diabetes, seizures, migraines • Dx?
J Fam Pract. 2023 Sep;72(7):E30-E32. doi: 10.12788/jfp.0651.ABSTRACT► large joint arthralgias ► history of type 1 diabetes, seizures, migraines.PMID:37729147 | DOI:10.12788/jfp.0651
Source: The Journal of Family Practice - September 20, 2023 Category: Practice Management Authors: Asher George Stephen Rayborn Peyton Herrington Svenja Albrecht Adrian Billings Source Type: research
Food and drinks to avoid if you suffer from migraines - doctor's advice
Dr Kiran Johal revealed the dietary, environmental, and emotional triggers for a migraine - and how to reduce the likelihood of having a painful headache.
Source: Daily Express - Health - September 19, 2023 Category: Consumer Health News Source Type: news
Evaluation of the Effect of Erenumab on Migraine ‐Specific Questionnaire in Patients with Chronic and Episodic Migraine.
AbstractErenumab is a fully human anti-canonical calcitonin gene-related peptide receptor monoclonal antibody approved for migraine prevention. The Migraine-Specific Quality-of-Life Questionnaire (MSQ) is a 14-item patient-reported outcome instrument that measures the impact of migraine on health-related quality of life. Erenumab data from 4 phase 2/3 clinical trials were used to develop an Item Response Theory model within a non-linear mixed effects framework to (i) evaluate MSQ item information with respect to patient disability, (ii) characterize the longitidunal progression of MSQ, and (iii) quantify the effect of eren...
Source: CPT: Pharmacometrics and Systems Pharmacology - September 19, 2023 Category: Drugs & Pharmacology Authors: Po ‐Wei Chen,
Mats O. Karlson,
Sebastian Ueckert,
Ari Pritchard‐Bell,
Cheng‐Pang Hsu,
Sandeep Dutta,
Malidi Ahamadi Tags: ARTICLE Source Type: research
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention —part 2: flunarizine
ConclusionsPublished flunarizine trials predate the recommended endpoints for evaluating migraine prophylaxis drugs, hence the lack of an adequate assessment for these endpoints. Further, modern-day, large ‐scale studies would be valuable in re-evaluating the efficacy of flunarizine for the treatment of migraines, offering additional insights into its potential benefits.
Source: The Journal of Headache and Pain - September 19, 2023 Category: Neurology Source Type: research
Prevalence of Primary Headache in Nurses in Japan: A Cross-sectional Single-center Study
Conclusion Migraines have a high prevalence (>20%) among nurses and are often under-diagnosed. In many cases, headache-associated symptoms are more important than laterality or other characteristics for the diagnosis. Many nurses are treated for headaches without a correct diagnosis. Further education regarding primary headaches may be necessary for health practitioners as well as society.PMID:37722898 | DOI:10.2169/internalmedicine.1757-23
Source: Internal Medicine - September 18, 2023 Category: Internal Medicine Authors: Koji Sekiguchi Sunjun Huh Narumi Watanabe Naoki Miyazaki Kei Ishizuchi Chisato Iba Yu Tagashira Mamoru Shibata Ryo Takemura Jin Nakahara Tsubasa Takizawa Source Type: research
Migraines and cardiovascular disease: mechanisms and methodological challenges
Nature Reviews Cardiology, Published online: 18 September 2023; doi:10.1038/s41569-023-00934-7The link between migraine and cardiovascular disease is complex and involves overlapping mechanisms, such as endovascular disturbances. Challenges in measuring migraine, in distinguishing between causation and prediction, and in the understanding of clinical implications highlight the need for further research to guide treatment and cardiovascular risk assessment for the millions of individuals living with migraine.
Source: Nature Reviews Cardiology - September 18, 2023 Category: Cardiology Authors: Tobias Kurth Pamela M. Rist Source Type: research
Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15 –39 years from 1990 to 2019: findings from the global burden of disease study 2019
ConclusionMigraine and TTH represent formidable challenges in global health. The intensity of their impact exhibits marked disparities across nations and is distinctly elevated among women, individuals within the 30 –39 age bracket, and populations characterized by a high SDI. The results of our research emphasize the imperative of assimilating migraine and TTH management into contemporary healthcare paradigms. Such strategic integration holds the potential to amplify public cognizance regarding pertinent ris k factors and the spectrum of therapeutic interventions at hand.
Source: The Journal of Headache and Pain - September 18, 2023 Category: Neurology Source Type: research
TikToker who suffers excruciating migraines reveals incredible household trick to lessen pain in seconds
Cass Cavanaugh, 21, from Missouri, posted a TikTok that showed them eating a whole lemon to help their migraine pain. 'When you get desperate enough with migraines, you'll try anything,' they said.
Source: the Mail online | Health - September 15, 2023 Category: Consumer Health News Source Type: news
Growing pains may indicate a greater risk of migraines later in life
A study of 100 children found that those who experience growing pains are more likely than their peers to get migraines five years later
Source: New Scientist - Health - September 15, 2023 Category: Consumer Health News Source Type: research
Response to 'Neurologists should retain diagnostic and therapeutic management of migraines'
Neurol Neurochir Pol. 2023 Sep 14. doi: 10.5603/pjnns.97421. Online ahead of print.NO ABSTRACTPMID:37706669 | DOI:10.5603/pjnns.97421
Source: Neurologia i Neurochirurgia Polska - September 14, 2023 Category: Neurology Authors: Magdalena Boczarska-Jedynak Source Type: research
Neurologists should retain diagnostic and therapeutic management of migraines
Neurol Neurochir Pol. 2023 Sep 14. doi: 10.5603/pjnns.96686. Online ahead of print.NO ABSTRACTPMID:37706667 | DOI:10.5603/pjnns.96686
Source: Neurologia i Neurochirurgia Polska - September 14, 2023 Category: Neurology Authors: Josef Finsterer Source Type: research
Response to 'Neurologists should retain diagnostic and therapeutic management of migraines'
Neurol Neurochir Pol. 2023 Sep 14. doi: 10.5603/pjnns.97421. Online ahead of print.NO ABSTRACTPMID:37706669 | DOI:10.5603/pjnns.97421
Source: Neurologia i Neurochirurgia Polska - September 14, 2023 Category: Neurology Authors: Magdalena Boczarska-Jedynak Source Type: research
